Acute Musculoskeletal Pain, Chronic Pain
Conditions
Keywords
Musculoskeletal Pain, Acute Pain, Emergency Department, Elderly, Video
Brief summary
The investigators have developed a three component intervention to support shared decision-making during the early recovery phase for older adults who present to the emergency department (ED) or orthopedic urgent care with acute musculoskeletal pain. The first component is a brief interactive video to enhance patient knowledge and self-efficacy regarding treatment options with the intent of facilitating conversations between patients and emergency providers. The second component is a protocol-guided phone conversation (telecare) between a nurse care manager and the patient at 48-72 hours following discharge to assess pain severity and interference with daily activities, review analgesic use and side effects and recovery-promoting behaviors, and discuss adjustments to the patients treatment. The third component is communication with the patient's primary care provider following the telecare call to inform them of the patient's condition and treatment plan and encourage primary care followup. The short-term objective of this project is to test the efficacy of this intervention to reduce the transition from acute to chronic musculoskeletal pain among older adults and obtain data to inform implementation. The investigators will conduct a three-arm randomized controlled trial with adults aged 50 years and older who present to the ED or orthopedic urgent care with acute musculoskeletal pain. Patients will be randomized to (1) the full intervention (video + telecare + communication with primary provider), (2) video alone, or (3) usual care. The primary outcome will be pain, measured longitudinally over the course of the year following the acute care visit. Secondary outcomes will include physical function, analgesic side effects and adverse events, opioid use, depression and anxiety symptoms, sleep duration and quality, and healthcare utilization at one, three, six, and twelve months. Secondary analyses will (1) examine whether the intervention has its effect by promoting shared decision-making, and (2) estimate the cost-effectiveness of the intervention. The long-term goal of this work is to develop, test, and implement interventions that improve long-term health outcomes for older adults with acute musculoskeletal pain.
Detailed description
Participants will be assigned to one of the three treatment arms using 1:1:1 randomization, stratified by access to a primary care provider, using randomly permuted blocks with random block sizes. (Primary care access will be determined using Source of Care questions from the Primary Care Assessment tool.) Randomization will be based on computer generated lists and allocated within subgroups based on access to a PCP using REDCap's integrated randomization module. One arm will receive the full intervention (educational video, telecare call, transmission of clinical information to the PCP), one will view the educational video only, and one will receive usual care. The investigators decided against a 2x2 factorial design, which would add a telecare only arm, because our team' s collective understanding is that a basic understanding of pain management (as provided by the educational video) is essential for effective shared decision-making (SDM) and often missing among older patients. Screening, consent, randomization, and assessments will be completed by the study coordinator. Interventions Educational Video: Development of the original video was funded by the John A. Hartford Foundation and used a systematic approach that included a review of literature and current pain management guidelines and input from emergency physicians, geriatricians, and experts in pharmacology, physical therapy, and risk communication. The video offers information about the pharmacologic management of acute musculoskeletal pain (MSP) and recovery-promoting behaviors. Each video section is followed by a multiple-choice question to promote interaction and reinforce learning. The actress for the 13-minute video is a 56-year-old mixed-race woman who presents herself as a healthcare provider. The video script was developed for a grade level 5.5 and will be shown to the patient within 24 hours of the acute care visit. A link to the video is emailed or texted to the patient. Telecare: Telecare will be provided via a protocol-guided phone call from a nurse care manager 48-72 hours after discharge. The call is designed to support patient decision-making regarding analgesics and behaviors following the content presented in the video. Before the call, the nurse will review the note from the index visit to obtain information about comorbidities, medications, allergies, and the patient's evaluation and treatment in the ED. Topics covered in the call will include discussion of pain management goals and priorities, current analgesic use, non-pharmacologic methods of pain management, warnings about potential side effects, and open-ended questions to address additional patient care needs. Conversations will be guided by an SDM framework in which the nurse elicits information from the patient, then discusses with the patient alternative strategies, and actively elicits feedback from the patient. Patients will be encouraged to follow-up with their PCP; uninsured patients will be referred to local free or low-cost medical clinics. The telecare call is designed to last 15 minutes and the nurse will be trained to complete the call in 15 minutes. Correspondence with PCP: Following the telecare conversation, the nurse will enter a note in the Electronic Health Record (EHR) documenting the patient's current clinical status, information reviewed, and any recommendations or referrals made. The nurse will then share this note directly with the patient's PCP using a secure e-mail or an electronic message within the EHR if the PCP is a University of North Carolina (UNC)-affiliated provider. (If the PCP's email address is not available, the research staff will contact the PCP or their office by phone to obtain an email address or fax number.) This communication with also include: (1) The date, time, location and reason for the initial visit; (2) Results of diagnostics studies; (3) Discharge prescriptions/recommendations; (4) A summary of and link to the video, explaining the emphasis on patient knowledge and SDM; (5) summary of the telecare conversation; and (6) encouragement for follow-up. PCPs will be asked to confirm receipt of this message. \*Study outcome measures as described in this CT.gov report have been revised as of September 6, 2023 in order to reflect the final Master Protocol.
Interventions
BEHAVIORALEducational Video
Educational Video: Development of the original video was funded by the John A. Hartford Foundation and used a systematic approach that included a review of literature and current pain management guidelines and input from emergency physicians, geriatricians, and experts in pharmacology, physical therapy, and risk communication. The video offers information about the pharmacologic management of acute musculoskeletal pain (MSP) and recovery-promoting behaviors. Each video section is followed by a multiple-choice question to promote interaction and reinforce learning. The actress for the 13-minute video is a 56-year-old mixed-race woman who presents herself as a healthcare provider. The video script was developed for a grade level 5.5 and will be shown to the patient within 24 hours of the acute care visit. A link to the video is emailed or texted to the patient.
BEHAVIORALTelecare
Telecare will be provided via a protocol-guided phone call from a nurse care manager 48-72 hours after discharge from the ED or orthopedic urgent care. The call is designed to support patient decision-making regarding analgesics and behaviors following the content presented in the video. Topics covered in the call will include discussion of goals and priorities the patient has for their pain management, current prescriptions and analgesic use (and adjustments if needed), non-pharmacologic methods of pain management, warnings about potential side effects, current healthcare utilization, and open-ended questions to address additional patient care needs. Conversations will be guided by a shared decision making framework in which the nurse suggests pain management options, discusses their pros and cons, and actively elicits feedback from the patient. The telecare call is designed to last 15 minutes.
BEHAVIORALCorrespondence with Primary Care Provider
Following the telecare conversation, a note will be sent directly to the patient's primary care provider using a secure email or an electronic message that includes: 1) The date, time, location and reason for the index visit; (2) Results of diagnostics studies; (3) Discharge prescriptions/ recommendations; (4) A summary of and link to the video, explaining the emphasis on patient knowledge and SDM; (5) A summary of the telecare conversation; and (6) Encouragement for follow-up. PCPs will be asked to confirm receipt of this message.
Sponsors
National Institute on Aging (NIA)
Duke University
Indiana University
Yale University
Elon University
University of North Carolina, Chapel Hill
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age 50 years and older * Present to UNC ED patient with primary complaint of acute musculoskeletal pain * Average pain score \>/= 4 on 0-10 scale * Expected discharge from the ED
Exclusion criteria
* patient does not speak English * primary pain located in the head, chest, or abdomen * pain due to ischemia, infection, or some other cause not due to MSP (blood clot, kidney stone, etc.) * primary pain due to self-injury * patient is critically ill determined by an acuity score of 1 in the tracking board * diagnosis of somatoform disorder, schizophrenia, dementia, or bipolar disorder * patient is a prisoner or in police custody * self-reported daily opioid use for more than 2 weeks * resides in a nursing home or is homeless * at-risk alcohol use * speech, hearing, vision problems * cognitively impaired (6-item Brief Screener) * nonworking phone number (follow-up occurs via phone calls)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Mean Brief Pain Inventory-Short Form (BPI-SF) Combined Pain Severity and Interference Score | Month 1 (following ED or orthopedic urgent care visit) to Month 6 | The Brief Pain Inventory-Short Form (BPI-SF) is an 11-item measure of pain severity and pain interference. Patients will rate their pain severity and interference over the past week on a 0-10 numeric scale at 3 discrete time periods (1, 3, and 6 months). End points for the severity items include 0 which equals no pain and 10 which equals pain as bad as you can imagine. End points for the interference items include 0 which equals does not interfere and 10 completely interferes. Higher scores reflect more pain severity and more pain interference. A composite score will be calculated by averaging scores from both the pain severity and interference items (all 11-items). Results from the 3 time periods will be analyzed longitudinally. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Mean Pain Interference on the BPI-SF Score | Up to 6 months | The BPI-SF is an 11-item measure of pain severity and pain interference with interference with daily activities entailing 7 of the questions. Patient's will rate their pain interference over the past week, on a 0-10 scale with a higher score reflecting more interference with activities. End points include 0 which equals does not interfere and 10 which equals completely interferes. Answers to each of the 7 questions will be reported as mean values for each time point (Month 1, 3, and 6). |
| Mean Symptom Distress Score | 1 week & 1 month | The Opioid-Related Symptom Distress Scale (OR-SDS) will be used to assess subject-reported levels of frequency and severity of 10 symptoms known to be associated with opioid medication usage, such as drowsiness, dizziness, and constipation. Added to this measure are 5 other symptoms (including shortness of breath, falls, abdominal pain, bloody stool, and 'other'), reflecting side effects for patients taking NSAIDs or acetaminophen. Symptom frequency will be rated as: 1=rarely, 2=occasionally, 3=frequently, or 4=almost constantly, with higher ratings indicating more frequent symptoms (ranging from 1 to 4). Symptom severity will be rated as: 1=slightly, 2-moderate, 3=severe, or 4=very severe, with higher ratings indicating more severe symptoms (ranging from 1 to 4). Patients who deny a symptom will be given a score of zero for frequency and severity. A mean symptom distress score was calculated for each arm based on patient reported scores for severity and frequency. |
| Percent of Participants With Opioid Use During the Past Week | 1, 3, 6, and 12 months | Patients will be asked if they have used opioids during the past week at each of the follow-up time points. This will be a dichotomous outcome in which 'yes' will indicate opioid use in the past week and 'no' will indicate no opioid use in the past week. |
| PROMIS Measure: Mean T-score Physical Function-4 | 1, 3, 6, and 12 months | Patient report of physical function will be measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function-4 for chores, ability to use stairs, walking, and running errands on a 5-point scale with end points of without any difficulty and unable to do. Higher scores reflect less difficulty. T-Score distributions are standardized such that a 50 represents the average (mean) for the US general population, and the standard deviation around that mean is 10 points. Therefore a person with a T-score of 40 is one SD below the mean. These values will be compared to the value obtained from the baseline assessment with patients reporting their function prior to injury. The data will be analyzed longitudinally for months 1, 3, 6, and 12 (following the approach for BPI for the primary outcome). |
| Mean Pain Severity on the Brief Pain Inventory-Short Form (BPI-SF) Score | Up to 6 months | The BPI-SF is an 11-item measure of pain severity and pain interference with severity entailing 4 of the questions. Patient's will rate their pain severity over the past week on a 0-10 numeric rating scale, with a higher score reflecting more pain. End points include 0 which equals no pain and 10 which equals pain as bad as you can imagine. Answers to each of the 4 questions will be reported as mean values for each time point (Month 1, 3, and 6). |
| Healthcare Utilization, Mean Days in the Hospital | Up to 12 months | The number of days the patient spent in the hospital after ED discharge will be collected through patient report and the patient's electronic health record. Analysis will compare these outcomes among study arms. |
| Healthcare Utilization, Mean Number of Visits to ED/Urgent Care | Up to 12 months | The number of visits to an ED or urgent care will be collected through patient report and the patient's electronic health record. Analysis will compare these outcomes among study arms. |
| Healthcare Utilization, Mean Number of Visits to Primary Care Provider | Up to 12 months | The number of visits to a primary care provider's office will be collected through patient report and the patient's electronic health record. Analysis will compare these outcomes among study arms. |
| PROMIS Measure: Mean T-score Global Health-Physical 2a | 1, 3, 6, and 12 months | Patient reported global health will be measured using the PROMIS Global Health-Physical 2a. General physical health is measured on a 5-point scale with end points of excellent and poor, where higher scores reflect better physical health. Ability to carry out every day physical activities is measured on a 5 point scale with end points of completely and not at all, where higher scores reflect better ability. T-Score distributions are standardized such that a 50 represents the average (mean) for the US general population, and the standard deviation around that mean is 10 points. Therefore a person with a T-score of 40 is one SD below the mean. These values will be compared to the value obtained from the baseline assessment with patients reporting their global health prior to injury. The data will be analyzed longitudinally for months 1, 3, 6, and 12 (following the approach for BPI for the primary outcome). |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Full Intervention (Video + Telecare + PCP Communication) Patients in this arm will watch an interactive pain management video; receive a pain assessment phone call and be given medication and behavioral pain management strategy recommendations; and an index visit and telecare summary will be shared with patient's primary care provider.
Educational Video: The video offers information about the pharmacologic management of acute musculoskeletal pain (MSP) and recovery-promoting behaviors. Each video section is followed by a multiple-choice question to promote interaction and reinforce learning. The video script was developed for a grade level 5.5 and will be shown to the patient within 24 hours of the acute care visit. A link to the video is emailed or texted to the patient.
Telecare: Telecare will be provided via a protocol-guided phone call from a nurse care manager 48-72 hours after discharge from the ED or orthopedic urgent care. The call is designed to support patient decision-making regarding analgesics and behaviors following the content presented in the video.
Correspondence with Primary Care Provider: Following the telecare conversation, a note will be sent directly to the patient's primary care provider using a secure email that includes: 1) The date, time, location and reason for the index visit; (2) Results of diagnostics studies; (3) Discharge prescriptions/ recommendations; (4) A summary of and link to the video; (5) A summary of the telecare conversation; and (6) Encouragement for follow-up. | 112 |
| Video-only Intervention Patients in this arm will watch an interactive pain management video.
Educational Video: The video offers information about the pharmacologic management of acute musculoskeletal pain (MSP) and recovery-promoting behaviors. Each video section is followed by a multiple-choice question to promote interaction and reinforce learning. The video script was developed for a grade level 5.5 and will be shown to the patient within 24 hours of the acute care visit. A link to the video is emailed or texted to the patient. | 107 |
| Usual Care Patients will receive the typical care provided by medical personnel for their acute pain. | 111 |
| Total | 330 |
Baseline characteristics
| Characteristic | Full Intervention (Video + Telecare + PCP Communication) | Video-only Intervention | Usual Care | Total |
|---|---|---|---|---|
| Age, Continuous | 64.8 years STANDARD_DEVIATION 9.9 | 65.1 years STANDARD_DEVIATION 8.8 | 64.4 years STANDARD_DEVIATION 8.7 | 64.7 years STANDARD_DEVIATION 9.1 |
| Age, Customized < 65 years old | 60 Participants | 58 Participants | 59 Participants | 177 Participants |
| Age, Customized 65 years old or greater | 52 Participants | 49 Participants | 52 Participants | 153 Participants |
| Ethnicity (NIH/OMB) Hispanic or Latino | 4 Participants | 3 Participants | 4 Participants | 11 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 108 Participants | 104 Participants | 107 Participants | 319 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Asian | 3 Participants | 1 Participants | 0 Participants | 4 Participants |
| Race (NIH/OMB) Black or African American | 17 Participants | 17 Participants | 18 Participants | 52 Participants |
| Race (NIH/OMB) More than one race | 0 Participants | 1 Participants | 2 Participants | 3 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 9 Participants | 14 Participants | 9 Participants | 32 Participants |
| Race (NIH/OMB) White | 83 Participants | 74 Participants | 82 Participants | 239 Participants |
| Region of Enrollment United States | 112 Participants | 107 Participants | 111 Participants | 330 Participants |
| Sex: Female, Male Female | 82 Participants | 72 Participants | 72 Participants | 226 Participants |
| Sex: Female, Male Male | 30 Participants | 35 Participants | 39 Participants | 104 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk |
|---|---|---|---|
| deaths Total, all-cause mortality | 0 / 112 | 1 / 107 | 1 / 111 |
| other Total, other adverse events | 38 / 112 | 39 / 107 | 35 / 111 |
| serious Total, serious adverse events | 6 / 112 | 3 / 107 | 13 / 111 |
Outcome results
Primary
Mean Brief Pain Inventory-Short Form (BPI-SF) Combined Pain Severity and Interference Score
The Brief Pain Inventory-Short Form (BPI-SF) is an 11-item measure of pain severity and pain interference. Patients will rate their pain severity and interference over the past week on a 0-10 numeric scale at 3 discrete time periods (1, 3, and 6 months). End points for the severity items include 0 which equals no pain and 10 which equals pain as bad as you can imagine. End points for the interference items include 0 which equals does not interfere and 10 completely interferes. Higher scores reflect more pain severity and more pain interference. A composite score will be calculated by averaging scores from both the pain severity and interference items (all 11-items). Results from the 3 time periods will be analyzed longitudinally.
Time frame: Month 1 (following ED or orthopedic urgent care visit) to Month 6
Population: Data are reported for all participants who completed each Follow-up within the 7-day window. There was participant attrition over time as shown in the Participant Flow.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Full Intervention (Video + Telecare + PCP Communication) | Mean Brief Pain Inventory-Short Form (BPI-SF) Combined Pain Severity and Interference Score | Month 3 | 1.90 score on a scale | Standard Deviation 1.8 |
| Full Intervention (Video + Telecare + PCP Communication) | Mean Brief Pain Inventory-Short Form (BPI-SF) Combined Pain Severity and Interference Score | Month 1 | 2.67 score on a scale | Standard Deviation 2.09 |
| Full Intervention (Video + Telecare + PCP Communication) | Mean Brief Pain Inventory-Short Form (BPI-SF) Combined Pain Severity and Interference Score | Month 6 | 2.22 score on a scale | Standard Deviation 2.21 |
| Video-only Intervention | Mean Brief Pain Inventory-Short Form (BPI-SF) Combined Pain Severity and Interference Score | Month 3 | 2.18 score on a scale | Standard Deviation 2.15 |
| Video-only Intervention | Mean Brief Pain Inventory-Short Form (BPI-SF) Combined Pain Severity and Interference Score | Month 1 | 2.99 score on a scale | Standard Deviation 2.12 |
| Video-only Intervention | Mean Brief Pain Inventory-Short Form (BPI-SF) Combined Pain Severity and Interference Score | Month 6 | 2.35 score on a scale | Standard Deviation 2.46 |
| Usual Care | Mean Brief Pain Inventory-Short Form (BPI-SF) Combined Pain Severity and Interference Score | Month 1 | 2.94 score on a scale | Standard Deviation 2.29 |
| Usual Care | Mean Brief Pain Inventory-Short Form (BPI-SF) Combined Pain Severity and Interference Score | Month 6 | 2.84 score on a scale | Standard Deviation 2.41 |
| Usual Care | Mean Brief Pain Inventory-Short Form (BPI-SF) Combined Pain Severity and Interference Score | Month 3 | 2.57 score on a scale | Standard Deviation 2.34 |
p-value: 0.13ANCOVA
Secondary
Healthcare Utilization, Mean Days in the Hospital
The number of days the patient spent in the hospital after ED discharge will be collected through patient report and the patient's electronic health record. Analysis will compare these outcomes among study arms.
Time frame: Up to 12 months
Population: Data are reported for all participants who completed each Follow-up within the 7-day window. There was participant attrition over time as shown in the Participant Flow.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Full Intervention (Video + Telecare + PCP Communication) | Healthcare Utilization, Mean Days in the Hospital | Month 1 | 0.04 Days | Standard Deviation 0.3 |
| Full Intervention (Video + Telecare + PCP Communication) | Healthcare Utilization, Mean Days in the Hospital | Month 3 | 0.16 Days | Standard Deviation 1.22 |
| Full Intervention (Video + Telecare + PCP Communication) | Healthcare Utilization, Mean Days in the Hospital | Month 6 | 0.00 Days | Standard Deviation 0 |
| Full Intervention (Video + Telecare + PCP Communication) | Healthcare Utilization, Mean Days in the Hospital | Month 12 | 0.23 Days | Standard Deviation 1.09 |
| Video-only Intervention | Healthcare Utilization, Mean Days in the Hospital | Month 12 | 0.09 Days | Standard Deviation 0.39 |
| Video-only Intervention | Healthcare Utilization, Mean Days in the Hospital | Month 1 | 0.00 Days | Standard Deviation 0 |
| Video-only Intervention | Healthcare Utilization, Mean Days in the Hospital | Month 6 | 0.07 Days | Standard Deviation 0.62 |
| Video-only Intervention | Healthcare Utilization, Mean Days in the Hospital | Month 3 | 0.01 Days | Standard Deviation 0.1 |
| Usual Care | Healthcare Utilization, Mean Days in the Hospital | Month 12 | 0.13 Days | Standard Deviation 0.39 |
| Usual Care | Healthcare Utilization, Mean Days in the Hospital | Month 3 | 0.10 Days | Standard Deviation 0.67 |
| Usual Care | Healthcare Utilization, Mean Days in the Hospital | Month 6 | 0.17 Days | Standard Deviation 1.23 |
| Usual Care | Healthcare Utilization, Mean Days in the Hospital | Month 1 | 0.05 Days | Standard Deviation 0.29 |
p-value: 0.15ANCOVA
Secondary
Healthcare Utilization, Mean Number of Visits to ED/Urgent Care
The number of visits to an ED or urgent care will be collected through patient report and the patient's electronic health record. Analysis will compare these outcomes among study arms.
Time frame: Up to 12 months
Population: Data are reported for all participants who completed each Follow-up within the 7-day window. There was participant attrition over time as shown in the Participant Flow.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Full Intervention (Video + Telecare + PCP Communication) | Healthcare Utilization, Mean Number of Visits to ED/Urgent Care | Month 1 | 0.09 visits | Standard Deviation 0.35 |
| Full Intervention (Video + Telecare + PCP Communication) | Healthcare Utilization, Mean Number of Visits to ED/Urgent Care | Month 3 | 0.25 visits | Standard Deviation 0.85 |
| Full Intervention (Video + Telecare + PCP Communication) | Healthcare Utilization, Mean Number of Visits to ED/Urgent Care | Month 6 | 0.30 visits | Standard Deviation 1.45 |
| Full Intervention (Video + Telecare + PCP Communication) | Healthcare Utilization, Mean Number of Visits to ED/Urgent Care | Month 12 | 0.40 visits | Standard Deviation 1.21 |
| Video-only Intervention | Healthcare Utilization, Mean Number of Visits to ED/Urgent Care | Month 12 | 0.35 visits | Standard Deviation 0.76 |
| Video-only Intervention | Healthcare Utilization, Mean Number of Visits to ED/Urgent Care | Month 1 | 0.06 visits | Standard Deviation 0.24 |
| Video-only Intervention | Healthcare Utilization, Mean Number of Visits to ED/Urgent Care | Month 6 | 0.26 visits | Standard Deviation 0.71 |
| Video-only Intervention | Healthcare Utilization, Mean Number of Visits to ED/Urgent Care | Month 3 | 0.08 visits | Standard Deviation 0.31 |
| Usual Care | Healthcare Utilization, Mean Number of Visits to ED/Urgent Care | Month 12 | 0.35 visits | Standard Deviation 0.74 |
| Usual Care | Healthcare Utilization, Mean Number of Visits to ED/Urgent Care | Month 3 | 0.25 visits | Standard Deviation 0.62 |
| Usual Care | Healthcare Utilization, Mean Number of Visits to ED/Urgent Care | Month 6 | 0.40 visits | Standard Deviation 1.08 |
| Usual Care | Healthcare Utilization, Mean Number of Visits to ED/Urgent Care | Month 1 | 0.04 visits | Standard Deviation 0.19 |
p-value: 0.04ANCOVA
Secondary
Healthcare Utilization, Mean Number of Visits to Primary Care Provider
The number of visits to a primary care provider's office will be collected through patient report and the patient's electronic health record. Analysis will compare these outcomes among study arms.
Time frame: Up to 12 months
Population: Data are reported for all participants who completed each Follow-up within the 7-day window. There was participant attrition over time as shown in the Participant Flow.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Full Intervention (Video + Telecare + PCP Communication) | Healthcare Utilization, Mean Number of Visits to Primary Care Provider | Month 1 | 0.15 visits | Standard Deviation 0.43 |
| Full Intervention (Video + Telecare + PCP Communication) | Healthcare Utilization, Mean Number of Visits to Primary Care Provider | Month 3 | 0.50 visits | Standard Deviation 0.78 |
| Full Intervention (Video + Telecare + PCP Communication) | Healthcare Utilization, Mean Number of Visits to Primary Care Provider | Month 6 | 0.70 visits | Standard Deviation 0.82 |
| Full Intervention (Video + Telecare + PCP Communication) | Healthcare Utilization, Mean Number of Visits to Primary Care Provider | Month 12 | 1.50 visits | Standard Deviation 1.73 |
| Video-only Intervention | Healthcare Utilization, Mean Number of Visits to Primary Care Provider | Month 12 | 1.10 visits | Standard Deviation 1.12 |
| Video-only Intervention | Healthcare Utilization, Mean Number of Visits to Primary Care Provider | Month 1 | 0.22 visits | Standard Deviation 0.48 |
| Video-only Intervention | Healthcare Utilization, Mean Number of Visits to Primary Care Provider | Month 6 | 0.79 visits | Standard Deviation 1.05 |
| Video-only Intervention | Healthcare Utilization, Mean Number of Visits to Primary Care Provider | Month 3 | 0.42 visits | Standard Deviation 0.86 |
| Usual Care | Healthcare Utilization, Mean Number of Visits to Primary Care Provider | Month 12 | 1.39 visits | Standard Deviation 1.35 |
| Usual Care | Healthcare Utilization, Mean Number of Visits to Primary Care Provider | Month 3 | 0.53 visits | Standard Deviation 0.77 |
| Usual Care | Healthcare Utilization, Mean Number of Visits to Primary Care Provider | Month 6 | 0.81 visits | Standard Deviation 0.96 |
| Usual Care | Healthcare Utilization, Mean Number of Visits to Primary Care Provider | Month 1 | 0.17 visits | Standard Deviation 0.42 |
p-value: 0.36ANCOVA
Secondary
Mean Pain Interference on the BPI-SF Score
The BPI-SF is an 11-item measure of pain severity and pain interference with interference with daily activities entailing 7 of the questions. Patient's will rate their pain interference over the past week, on a 0-10 scale with a higher score reflecting more interference with activities. End points include 0 which equals does not interfere and 10 which equals completely interferes. Answers to each of the 7 questions will be reported as mean values for each time point (Month 1, 3, and 6).
Time frame: Up to 6 months
Population: Data are reported for all participants who completed each Follow-up within the 7-day window. There was participant attrition over time as shown in the Participant Flow.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Full Intervention (Video + Telecare + PCP Communication) | Mean Pain Interference on the BPI-SF Score | Month 6 | 2.14 score on a scale | Standard Deviation 2.43 |
| Full Intervention (Video + Telecare + PCP Communication) | Mean Pain Interference on the BPI-SF Score | Month 1 | 2.64 score on a scale | Standard Deviation 2.4 |
| Full Intervention (Video + Telecare + PCP Communication) | Mean Pain Interference on the BPI-SF Score | Month 3 | 1.82 score on a scale | Standard Deviation 1.99 |
| Video-only Intervention | Mean Pain Interference on the BPI-SF Score | Month 6 | 2.26 score on a scale | Standard Deviation 2.72 |
| Video-only Intervention | Mean Pain Interference on the BPI-SF Score | Month 1 | 3.04 score on a scale | Standard Deviation 2.51 |
| Video-only Intervention | Mean Pain Interference on the BPI-SF Score | Month 3 | 2.14 score on a scale | Standard Deviation 2.38 |
| Usual Care | Mean Pain Interference on the BPI-SF Score | Month 6 | 2.88 score on a scale | Standard Deviation 2.76 |
| Usual Care | Mean Pain Interference on the BPI-SF Score | Month 3 | 2.61 score on a scale | Standard Deviation 2.64 |
| Usual Care | Mean Pain Interference on the BPI-SF Score | Month 1 | 2.98 score on a scale | Standard Deviation 2.7 |
p-value: 0.08ANCOVA
Secondary
Mean Pain Severity on the Brief Pain Inventory-Short Form (BPI-SF) Score
The BPI-SF is an 11-item measure of pain severity and pain interference with severity entailing 4 of the questions. Patient's will rate their pain severity over the past week on a 0-10 numeric rating scale, with a higher score reflecting more pain. End points include 0 which equals no pain and 10 which equals pain as bad as you can imagine. Answers to each of the 4 questions will be reported as mean values for each time point (Month 1, 3, and 6).
Time frame: Up to 6 months
Population: Data are reported for all participants who completed each Follow-up within the 7-day window. There was participant attrition over time as shown in the Participant Flow.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Full Intervention (Video + Telecare + PCP Communication) | Mean Pain Severity on the Brief Pain Inventory-Short Form (BPI-SF) Score | Month 3 | 1.98 score on a scale | Standard Deviation 1.79 |
| Full Intervention (Video + Telecare + PCP Communication) | Mean Pain Severity on the Brief Pain Inventory-Short Form (BPI-SF) Score | Month 1 | 2.69 score on a scale | Standard Deviation 2 |
| Full Intervention (Video + Telecare + PCP Communication) | Mean Pain Severity on the Brief Pain Inventory-Short Form (BPI-SF) Score | Month 6 | 2.30 score on a scale | Standard Deviation 2.14 |
| Video-only Intervention | Mean Pain Severity on the Brief Pain Inventory-Short Form (BPI-SF) Score | Month 3 | 2.22 score on a scale | Standard Deviation 2.1 |
| Video-only Intervention | Mean Pain Severity on the Brief Pain Inventory-Short Form (BPI-SF) Score | Month 1 | 2.94 score on a scale | Standard Deviation 1.97 |
| Video-only Intervention | Mean Pain Severity on the Brief Pain Inventory-Short Form (BPI-SF) Score | Month 6 | 2.45 score on a scale | Standard Deviation 2.42 |
| Usual Care | Mean Pain Severity on the Brief Pain Inventory-Short Form (BPI-SF) Score | Month 1 | 2.90 score on a scale | Standard Deviation 2.14 |
| Usual Care | Mean Pain Severity on the Brief Pain Inventory-Short Form (BPI-SF) Score | Month 6 | 2.81 score on a scale | Standard Deviation 2.27 |
| Usual Care | Mean Pain Severity on the Brief Pain Inventory-Short Form (BPI-SF) Score | Month 3 | 2.53 score on a scale | Standard Deviation 2.25 |
p-value: 0.41ANCOVA
Secondary
Mean Symptom Distress Score
The Opioid-Related Symptom Distress Scale (OR-SDS) will be used to assess subject-reported levels of frequency and severity of 10 symptoms known to be associated with opioid medication usage, such as drowsiness, dizziness, and constipation. Added to this measure are 5 other symptoms (including shortness of breath, falls, abdominal pain, bloody stool, and 'other'), reflecting side effects for patients taking NSAIDs or acetaminophen. Symptom frequency will be rated as: 1=rarely, 2=occasionally, 3=frequently, or 4=almost constantly, with higher ratings indicating more frequent symptoms (ranging from 1 to 4). Symptom severity will be rated as: 1=slightly, 2-moderate, 3=severe, or 4=very severe, with higher ratings indicating more severe symptoms (ranging from 1 to 4). Patients who deny a symptom will be given a score of zero for frequency and severity. A mean symptom distress score was calculated for each arm based on patient reported scores for severity and frequency.
Time frame: 1 week & 1 month
Population: Data are reported for all participants who completed each Follow-up within the 7-day window. There was participant attrition over time as shown in the Participant Flow.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Full Intervention (Video + Telecare + PCP Communication) | Mean Symptom Distress Score | Week 1 | 0.062 score on a scale | Standard Deviation 0.138 |
| Full Intervention (Video + Telecare + PCP Communication) | Mean Symptom Distress Score | Month 1 | 0.023 score on a scale | Standard Deviation 0.08 |
| Video-only Intervention | Mean Symptom Distress Score | Week 1 | 0.063 score on a scale | Standard Deviation 0.164 |
| Video-only Intervention | Mean Symptom Distress Score | Month 1 | 0.019 score on a scale | Standard Deviation 0.065 |
| Usual Care | Mean Symptom Distress Score | Week 1 | 0.043 score on a scale | Standard Deviation 0.103 |
| Usual Care | Mean Symptom Distress Score | Month 1 | 0.015 score on a scale | Standard Deviation 0.058 |
p-value: 0.64ANCOVA
Secondary
Percent of Participants With Opioid Use During the Past Week
Patients will be asked if they have used opioids during the past week at each of the follow-up time points. This will be a dichotomous outcome in which 'yes' will indicate opioid use in the past week and 'no' will indicate no opioid use in the past week.
Time frame: 1, 3, 6, and 12 months
Population: Data are reported for all participants who completed each Follow-up within the 7-day window. There was participant attrition over time as shown in the Participant Flow.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Full Intervention (Video + Telecare + PCP Communication) | Percent of Participants With Opioid Use During the Past Week | Month 1-Yes | 5.6 percentage of participants |
| Full Intervention (Video + Telecare + PCP Communication) | Percent of Participants With Opioid Use During the Past Week | Month 3-Yes | 1.9 percentage of participants |
| Full Intervention (Video + Telecare + PCP Communication) | Percent of Participants With Opioid Use During the Past Week | Month 6-Yes | 2.9 percentage of participants |
| Full Intervention (Video + Telecare + PCP Communication) | Percent of Participants With Opioid Use During the Past Week | Month 12-Yes | 3.0 percentage of participants |
| Video-only Intervention | Percent of Participants With Opioid Use During the Past Week | Month 12-Yes | 3.4 percentage of participants |
| Video-only Intervention | Percent of Participants With Opioid Use During the Past Week | Month 1-Yes | 9.0 percentage of participants |
| Video-only Intervention | Percent of Participants With Opioid Use During the Past Week | Month 6-Yes | 3.1 percentage of participants |
| Video-only Intervention | Percent of Participants With Opioid Use During the Past Week | Month 3-Yes | 1.0 percentage of participants |
| Usual Care | Percent of Participants With Opioid Use During the Past Week | Month 12-Yes | 6.3 percentage of participants |
| Usual Care | Percent of Participants With Opioid Use During the Past Week | Month 3-Yes | 4.9 percentage of participants |
| Usual Care | Percent of Participants With Opioid Use During the Past Week | Month 6-Yes | 5.9 percentage of participants |
| Usual Care | Percent of Participants With Opioid Use During the Past Week | Month 1-Yes | 5.7 percentage of participants |
p-value: 0.57ANCOVA
Secondary
PROMIS Measure: Mean T-score Global Health-Physical 2a
Patient reported global health will be measured using the PROMIS Global Health-Physical 2a. General physical health is measured on a 5-point scale with end points of excellent and poor, where higher scores reflect better physical health. Ability to carry out every day physical activities is measured on a 5 point scale with end points of completely and not at all, where higher scores reflect better ability. T-Score distributions are standardized such that a 50 represents the average (mean) for the US general population, and the standard deviation around that mean is 10 points. Therefore a person with a T-score of 40 is one SD below the mean. These values will be compared to the value obtained from the baseline assessment with patients reporting their global health prior to injury. The data will be analyzed longitudinally for months 1, 3, 6, and 12 (following the approach for BPI for the primary outcome).
Time frame: 1, 3, 6, and 12 months
Population: Data are reported for all participants who completed each Follow-up within the 7-day window. There was participant attrition over time as shown in the Participant Flow.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Full Intervention (Video + Telecare + PCP Communication) | PROMIS Measure: Mean T-score Global Health-Physical 2a | Month 1 | 47.73 T-score | Standard Deviation 7.89 |
| Full Intervention (Video + Telecare + PCP Communication) | PROMIS Measure: Mean T-score Global Health-Physical 2a | Month 3 | 49.67 T-score | Standard Deviation 7.14 |
| Full Intervention (Video + Telecare + PCP Communication) | PROMIS Measure: Mean T-score Global Health-Physical 2a | Month 6 | 49.68 T-score | Standard Deviation 8.91 |
| Full Intervention (Video + Telecare + PCP Communication) | PROMIS Measure: Mean T-score Global Health-Physical 2a | Month 12 | 50.08 T-score | Standard Deviation 7.92 |
| Video-only Intervention | PROMIS Measure: Mean T-score Global Health-Physical 2a | Month 12 | 49.16 T-score | Standard Deviation 8.69 |
| Video-only Intervention | PROMIS Measure: Mean T-score Global Health-Physical 2a | Month 1 | 45.72 T-score | Standard Deviation 7.54 |
| Video-only Intervention | PROMIS Measure: Mean T-score Global Health-Physical 2a | Month 6 | 47.87 T-score | Standard Deviation 8.69 |
| Video-only Intervention | PROMIS Measure: Mean T-score Global Health-Physical 2a | Month 3 | 48.55 T-score | Standard Deviation 8.14 |
| Usual Care | PROMIS Measure: Mean T-score Global Health-Physical 2a | Month 12 | 47.78 T-score | Standard Deviation 8.58 |
| Usual Care | PROMIS Measure: Mean T-score Global Health-Physical 2a | Month 3 | 47.47 T-score | Standard Deviation 9.42 |
| Usual Care | PROMIS Measure: Mean T-score Global Health-Physical 2a | Month 6 | 47.52 T-score | Standard Deviation 8.89 |
| Usual Care | PROMIS Measure: Mean T-score Global Health-Physical 2a | Month 1 | 46.75 T-score | Standard Deviation 8.24 |
p-value: 0.19ANCOVA
Secondary
PROMIS Measure: Mean T-score Physical Function-4
Patient report of physical function will be measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function-4 for chores, ability to use stairs, walking, and running errands on a 5-point scale with end points of without any difficulty and unable to do. Higher scores reflect less difficulty. T-Score distributions are standardized such that a 50 represents the average (mean) for the US general population, and the standard deviation around that mean is 10 points. Therefore a person with a T-score of 40 is one SD below the mean. These values will be compared to the value obtained from the baseline assessment with patients reporting their function prior to injury. The data will be analyzed longitudinally for months 1, 3, 6, and 12 (following the approach for BPI for the primary outcome).
Time frame: 1, 3, 6, and 12 months
Population: Data are reported for all participants who completed each Follow-up within the 7-day window. There was participant attrition over time as shown in the Participant Flow. One participant in the Full Intervention (Video + Telecare + PCP communication) arm did not complete the 3 month assessment.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Full Intervention (Video + Telecare + PCP Communication) | PROMIS Measure: Mean T-score Physical Function-4 | Month 1 | 42.19 T-score | Standard Deviation 8.1 |
| Full Intervention (Video + Telecare + PCP Communication) | PROMIS Measure: Mean T-score Physical Function-4 | Month 3 | 45.25 T-score | Standard Deviation 8.23 |
| Full Intervention (Video + Telecare + PCP Communication) | PROMIS Measure: Mean T-score Physical Function-4 | Month 6 | 45.88 T-score | Standard Deviation 9 |
| Full Intervention (Video + Telecare + PCP Communication) | PROMIS Measure: Mean T-score Physical Function-4 | Month 12 | 47.44 T-score | Standard Deviation 8.54 |
| Video-only Intervention | PROMIS Measure: Mean T-score Physical Function-4 | Month 12 | 46.29 T-score | Standard Deviation 8.94 |
| Video-only Intervention | PROMIS Measure: Mean T-score Physical Function-4 | Month 1 | 40.83 T-score | Standard Deviation 8.26 |
| Video-only Intervention | PROMIS Measure: Mean T-score Physical Function-4 | Month 6 | 44.41 T-score | Standard Deviation 8.98 |
| Video-only Intervention | PROMIS Measure: Mean T-score Physical Function-4 | Month 3 | 44.21 T-score | Standard Deviation 8.51 |
| Usual Care | PROMIS Measure: Mean T-score Physical Function-4 | Month 12 | 44.50 T-score | Standard Deviation 9.54 |
| Usual Care | PROMIS Measure: Mean T-score Physical Function-4 | Month 3 | 43.49 T-score | Standard Deviation 9.26 |
| Usual Care | PROMIS Measure: Mean T-score Physical Function-4 | Month 6 | 43.51 T-score | Standard Deviation 9.23 |
| Usual Care | PROMIS Measure: Mean T-score Physical Function-4 | Month 1 | 41.17 T-score | Standard Deviation 8.54 |
p-value: 0.43ANCOVA